Cargando…
Clinical Utility of Plasma KRAS, NRAS and BRAF Mutational Analysis with Real Time PCR in Metastatic Colorectal Cancer Patients—The Importance of Tissue/Plasma Discordant Cases
Background: Tumor tissue (T) mutational analysis represents the standard for metastatic colorectal cancer (mCRC); however, circulating tumor DNA (ctDNA) detected by liquid biopsy in plasma (PL) can better represent tumor heterogeneity. Methods: mCRC patients undergoing standard first-line chemothera...
Autores principales: | Formica, Vincenzo, Lucchetti, Jessica, Doldo, Elena, Riondino, Silvia, Morelli, Cristina, Argirò, Renato, Renzi, Nicola, Nitti, Daniele, Nardecchia, Antonella, Dell’Aquila, Emanuela, Ferroni, Patrizia, Guadagni, Fiorella, Palmieri, Giampiero, Orlandi, Augusto, Roselli, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794782/ https://www.ncbi.nlm.nih.gov/pubmed/33383664 http://dx.doi.org/10.3390/jcm10010087 |
Ejemplares similares
-
Concordance of Blood-Based and Normal Tissue-Based Dihydropyrimidine
Dehydrogenase (DPYD) Genotyping
por: Morelli, Cristina, et al.
Publicado: (2022) -
Prognostic value of glycated hemoglobin in colorectal cancer
por: Ferroni, Patrizia, et al.
Publicado: (2016) -
Venous Thromboembolism in Cancer Patients on Simultaneous and Palliative Care
por: Riondino, Silvia, et al.
Publicado: (2020) -
Clinical significance of glycemic parameters on venous thromboembolism risk prediction in gastrointestinal cancer
por: Guadagni, Fiorella, et al.
Publicado: (2017) -
Predicting VTE in Cancer Patients: Candidate Biomarkers and Risk Assessment Models
por: Riondino, Silvia, et al.
Publicado: (2019)